HIS : Training Tanzanian Researchers for HIV/AIDS Implementation Science (Renewal)

项目概要/摘要：坦桑尼亚是撒哈拉以南非洲受影响严重的国家之一 艾滋病的蔓延。坦桑尼亚面临着未完成的艾滋病毒检测、治疗和病毒抑制议程， 执行差距，特别是在儿童，青少年和年轻人。坦桑尼亚也处于早期 评估整合非传染性疾病筛查、预防和护理战略的阶段 （非传染性疾病）纳入对艾滋病毒感染者的护理。艾滋病毒护理和治疗方案的长期成功， 通过这种“培训坦桑尼亚人”，可以确保和改善坦桑尼亚艾滋病毒目标的实现。 研究人员促进艾滋病毒/艾滋病实施科学”培训计划，一项更新申请和联合倡议 由哈佛T. H.波士顿Chan公共卫生学院（HSPH）和Muhimbili卫生大学， 达累斯萨拉姆的联合科学公司。哈佛大学与MUHAS的合作在三个主要方面建立了优势 艾滋病研究领域：（1）公共卫生干预措施和影响评估;（2） 艾滋病护理和治疗方案服务;（3）研究培训。在最初的五年里，艾滋病毒 实施科学培训计划达到或超过了其每一个培训目标，其中包括推出 在MUHAS的实施科学的公共卫生新硕士。为了这次续约， 将侧重于与三个新的优先研究领域有关的艾滋病毒实施研究， 与坦桑尼亚决策者和艾滋病毒方案执行者进行讨论，包括：㈠受艾滋病毒影响的儿童 （包括感染艾滋病毒的儿童和接触艾滋病毒但未感染的儿童），（ii）青少年艾滋病毒，和（iii）艾滋病毒， 营养和非传染性疾病该计划旨在（1）培养一批中级和高级研究人员， 作为主要研究者，领导独立研究项目，专注于实施科学问题 并在博士水平上教授实施科学研究方法;（2）建立一个初级的临界质量 公共卫生和医疗专业人员谁可以设计和成功地进行严格的研究项目， 艾滋病毒实施科学、影响评估和卫生系统研究;以及（3）扩大 艾滋病毒实施科学研究人员通过开发一个新的博士课程在实施科学在 穆哈斯。该培训计划的核心是波士顿和达累斯萨拉姆的五项战略， 实现这些具体目标，包括：培养5名博士后研究员，15名硕士研究员，5名博士研究员， 在达累斯萨拉姆提供12个短期课程，将达到约500名学习者，并举办5个年度MUHAS-哈佛 与政府、实施者、研究人员、教职员工和研究员进行接触的研讨会。我们还将推出新的 博士在MUHAS的实施科学。通过基于相互尊重和伙伴关系的办法， 我们的合作培训计划将为研究员整合教育组件和资源， 他们的工具，成为艾滋病毒实施科学的独立领导者。

Project Summary/Abstract: Tanzania is one of the countries in sub-Saharan Africa that is severely affected by the HIV epidemic. Tanzania faces an unfinished HIV testing, treatment, and viral suppression agenda because of implementation gaps, particularly in children, adolescents, and young adults. Tanzania is also in the early stages of evaluating strategies to integrate screening, prevention, and care for non-communicable diseases (NCDs) into care for people living with HIV. The long-term success of HIV care and treatment programs and achievement of HIV targets in Tanzania can be ensured and improved through this “Training Tanzanian Researchers for HIV/AIDS Implementation Science” training program, a renewal application and joint initiative by the Harvard T.H. Chan School of Public Health (HSPH) in Boston and Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam. The Harvard-MUHAS collaboration has built strength in three main HIV research areas: (1) public health interventions and Impact Evaluation; (2) implementation research in programmatic HIV care and treatment services; and (3) research training. During the first five years, the HIV Implementation Science training program met or exceeded each of its training aims which included the launch of a new Master of Public Health in Implementation Science at MUHAS. For this renewal, the training program will focus on HIV implementation research related to three new priority research areas identified through discussions with Tanzanian policymakers and HIV program implementers, including: (i) HIV-affected children (including children living with HIV and HIV-exposed uninfected children), (ii) Adolescent HIV, and (iii) HIV, nutrition, and NCDs. The program aims to (1) train a critical mass of mid-level and senior researchers to work as principal investigators leading independent research programs focused on implementation science questions and teach implementation science research methods at the doctoral-level; (2) Build a critical mass of junior public health and medical professionals who can design and successfully carry out rigorous research projects in HIV Implementation Science, Impact Evaluation, and Health Systems Research; and (3) Extend the pipeline of HIV Implementation Science researchers by developing a new PhD program in Implementation Science at MUHAS. At the heart of this training program are five strategies both in Boston and in Dar es Salaam that will achieve these specific aims, including: training 5 Postdoctoral Fellows, 15 Masters Fellows, 5 Doctoral Fellows, offer 12 short courses in Dar es Salaam that will reach ~500 learners, and hold 5 annual MUHAS-Harvard symposia to engage with government, implementers, researchers, faculty, and fellows. We will also launch a new PhD in Implementation Science at MUHAS. Through an approach based on mutual respect and partnership, our collaborative training program will integrate educational components and resources for fellows, equipping them with tools to become independent leaders in HIV Implementation Science.